NVO - Ozempic Wegovy And Other Weight-Loss Drugs Won't Solve Global Obesity Crisis Affecting 1B People WHO Warns | Benzinga
The World Health Organization (WHO) has cautioned that the increasing global obesity crisis, which now affects over a billion people, cannot be resolved by the use of obesity medications alone.
What Happened: The WHO has warned that the use of effective and popular obesity medications will not be sufficient to address the growing global obesity crisis, which now affects over a billion people, reported Bloomberg.
The warning comes as obesity rates have quadrupled among children and teenagers and more than doubled among adults since 1990.
The WHO’s first global public analysis of the condition since 2017 revealed that approximately one in every eight individuals worldwide is living with obesity. While obesity rates have stabilized in some affluent nations, they are rapidly rising in low- and middle-income countries.
Although new obesity medications such as Novo Nordisk‘s (NYSE:NVO) Wegovy, Ozempic and Eli Lilly & Co‘s (NYSE:LLY) Zepbound could potentially create an ...